- Home
- KPRX vs OMEX Comparison
KPRX vs OMEX Comparison
Compare KPRX & OMEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- OMEX
- Stock Information
- Founded
- KPRX 1998
- OMEX 1986
- Country
- KPRX United States
- OMEX United States
- Employees
- KPRX N/A
- OMEX N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- OMEX Marine Transportation
- Sector
- KPRX Health Care
- OMEX Consumer Discretionary
- Exchange
- KPRX Nasdaq
- OMEX Nasdaq
- Market Cap
- KPRX 10.0M
- OMEX 9.3M
- IPO Year
- KPRX N/A
- OMEX N/A
- Fundamental
- Price
- KPRX $3.91
- OMEX $0.70
- Analyst Decision
- KPRX Strong Buy
- OMEX
- Analyst Count
- KPRX 1
- OMEX 0
- Target Price
- KPRX $10.00
- OMEX N/A
- AVG Volume (30 Days)
- KPRX 54.6K
- OMEX 2.4M
- Earning Date
- KPRX 11-08-2024
- OMEX 02-19-2025
- Dividend Yield
- KPRX N/A
- OMEX N/A
- EPS Growth
- KPRX N/A
- OMEX N/A
- EPS
- KPRX 1.69
- OMEX N/A
- Revenue
- KPRX $16,020,000.00
- OMEX $799,139.00
- Revenue This Year
- KPRX N/A
- OMEX N/A
- Revenue Next Year
- KPRX N/A
- OMEX N/A
- P/E Ratio
- KPRX $2.31
- OMEX $1.23
- Revenue Growth
- KPRX N/A
- OMEX N/A
- 52 Week Low
- KPRX $3.00
- OMEX $0.30
- 52 Week High
- KPRX $8.98
- OMEX $5.57
- Technical
- Relative Strength Index (RSI)
- KPRX 60.98
- OMEX 60.89
- Support Level
- KPRX $3.10
- OMEX $0.62
- Resistance Level
- KPRX $4.00
- OMEX $0.71
- Average True Range (ATR)
- KPRX 0.25
- OMEX 0.10
- MACD
- KPRX 0.02
- OMEX 0.00
- Stochastic Oscillator
- KPRX 90.00
- OMEX 52.72
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About OMEX Odyssey Marine Exploration Inc.
Odyssey Marine Exploration Inc is a deep-ocean exploration company. The company provides specialized mineral exploration, project development, and marine services to clients. It is engaged in the discovery, validation, and development of subsea mineral deposits in a socially and environmentally responsible manner. The company works with governments to identify mineral resources in Exclusive Economic Zones, focusing on phosphorite (fertilizer) and polymetallic nodule (battery metals) projects. Its projects include ExO Phosphate project, CIC, Ocean Minerals, and LIHIR Gold project.